Apeiron Synthesis
Helping improve and streamline production processes with state-of-the-art metathesis catalysts.
Helping improve and streamline production processes with state-of-the-art metathesis catalysts.
Apeiron Synthesis is a Polish-based startup dedicated to advancing olefin metathesis technology for various industrial applications. Founded in 2009, the company has recently secured a $4.80M Seed Round investment from Aper Ventures, Orlen, and Adamed Group at 21 December 2022.
Apeiron Synthesis aims to revolutionize production processes across industries by leveraging state-of-the-art metathesis catalysts. Their comprehensive portfolio comprising over twenty high-performance catalysts offers efficient and cost-effective solutions for R&D and commercial manufacturing processes. These catalysts have the potential to benefit numerous industries, including agrichemicals, fine chemicals, flavor and fragrances, polymers, and Pharma/Biopharma.
The company's relentless commitment to designing and utilizing robust new catalysts underscores its dedication to providing transformative metathesis technology. By enabling chemists to build complex molecules with fewer synthetic steps and byproducts, reduced waste, higher reaction concentrations, and lower costs, Apeiron Synthesis is making a significant impact on the field of synthetic chemistry.
With its pioneering efforts, Apeiron is at the forefront of diversifying the applications of catalytic olefin metathesis, positioning the technology as an essential component of every chemist's toolkit. This strategic approach, combined with its recent substantial investment, reinforces Apeiron Synthesis' potential for significant growth and influence in the chemical synthesis domain.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $4.80M | 3 |
|
21 Dec 2022 |
No recent news or press coverage available for Apeiron Synthesis.
We care about your data, and we'd love to use cookies make your experience better.